Semifluorinated Alkane Compositions

Patent No. EP3488847 (titled "Semifluorinated Alkane Compositions") was filed by Novaliq on Sep 12, 2013. The application was issued on Nov 8, 2023.

Patent Summary

A novel formulation for dry eye treatment that eliminates preservatives while maintaining therapeutic efficacy. The formulation comprises a semifluorinated alkane with a contact angle of 100-100°, which prevents microbial growth and irritation while maintaining tear film stability. The formulation can be used as a topical treatment for dry eye syndrome, including symptoms such as dryness, grittiness, and foreign body sensation.

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANDOZAug 7, 2024KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3488847

NOVALIQ
Application Number
EP18209639A
Filing Date
Sep 12, 2013
Status
Granted And Under Opposition
Oct 6, 2023
Publication Date
Nov 8, 2023